主动脉内球囊反搏的临床应用现状和进展被引量：7

Current situation and advances of clinical application of the intra-aortic balloon counterpulsation

下载PDF

导出

摘要主动脉内球囊反搏泵(IABP)通过主动脉内球囊在心脏舒张期快速充盈和收缩期快速排空的方式,改善冠状动脉血流灌注,同时降低心脏后负荷及心肌耗氧量。现广泛应用于急性心肌梗死合并心原性休克、血流动力学不稳定的高危经皮冠状动脉介入治疗等临床情况,取得了较好的临床疗效,但最新一些临床研究结果却得出了不同的结论,部分学者对IABP的临床应用有不同的意见及争论。当IABP主要的传统适应证面临极大的挑战时,而其潜在的适应证在临床中相继报道,IABP的适应证范围正逐步扩大,可能是未来IABP临床应用的发展方向。现就IABP临床应用的现状与进展做一综述。 Intra-aortic balloon pump （ IABP） can improve coronary flow and decrease after load and oxygen consumption by counterpulsation due to diastolic inflation and systolic deflation. Currently it is widely used for acute myocardial infarction （ AMI ） complicated by cardiogenic shock, high-risk percutaneous coronary intervention （PCI） with hemodynamic instability,and so other clinical conditions,achieved good clinical efficacy. However,some recent clinical study results do not fully support routine use of IABP in these settings. Some scholars have different opinions on this issue. When the major traditional indications of IABP are facing great challenges, potential indications have been reported progressively. Indications for IABP are gradually expanding outside traditional range. It may be the future development for IABP clinical applications. Now we discuss the clinical current situations and advances of IABP in this review.

作者徐承义刘成伟

机构地区武汉亚洲心脏病医院心内科

出处《中国心血管杂志》 2016年第4期327-331,共5页 Chinese Journal of Cardiovascular Medicine

关键词心肌梗死主动脉内球囊反搏泵高危经皮冠状动脉介入治疗进展 Myocardial infarction Intra-aortic balloon pump High risk percutaneous coronary intervention Progress

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献35

1Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock [J]. JAMA,1968 ,203 (2) :113-118.
2OGara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of eardiolog3, foundation/Ameriean heart association task force on practice guidelines [J]. J Am Coil Cardiol, 2013,61 (4) : e78-140. DOI : 10. 1016/j. jacc. 2012. 11. 019.
3WindeckerS, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularlzation [J]. Kardiol Pol,2014, 72(12) :1253-1379. DOI:I0. 5603/KP. 2014. 0224.
4Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et at. The current practice of intraaortic balloon counterpulsation: results from the Benchmark Registry [ J ] . J Am Coil Cardlol, 2001 , 38 ( 5 ) : 1456-1462.
5Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the BENCHMARK registry [ J]. J Am Coll Cardiol,2003,41 ( 11 ) : 1940-1945.
6Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon countecpulsation in patients with cardiogenic shock complicating acute myocardial infarction:data from the National Registry of Myocardial Infarction 2 [ J ]. Am Heart J, 2001,141 (6) :933-939. DOI:10. 1067/mhj. 2001. 115295.
7Prondzinsky R, Unverzagt S, Russ M, et at. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by eardiogenic shock: the prospective, randomized IABP shock trial [ J ] . Shock, 2012,37 (4) :378-384. DOI:10. 1097/SHK. ObO13e31824a67af.
8Thiele H, Zeymer U, Neumann FJ, et al. The IABP-SHOCK II Trial Investigators. lntraaortic balloon support for myocardial infarction with cardiogenic shock [ J ]. N Engl J Med, 2012,367 (14) : 1287-1296. DOI : 10. 1056/NEJMoa1208410.
9Subasit A, Atish M, Umashankar L, et al. Have we given up on intra-aortic balloon counterpulsation in post-myocardial infarction vardiogenic shock [ J ]? Clin Cardio, 2013, 36 ( 11 ): 704- 710. DOI:10. 1002/clc. 22184.
10Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization:a comprehensive meta-analysis [ J ] . Am Heart J, 2013,165 ( 5 ) : 679-692. DOI : 10. 1016/j. ahj. 2013.02. 020.

二级参考文献29

1Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction ; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction ). J Am Coil Cardiol, 2004,44 : e1 -211.
2Mahaffey KW, Kruse KR, Ohman EM. Perspectives on the use of intra-aortic balloon counterpulsation in the 1990s//Topol E J, editor. Textbook of Interventional Cardiology, Update Series, Update no. 21. Philadelphia:PA: W.B. Saunders, 1996:303- 320.
3Fotopoulos GD, Mason M J, Walker S, et al. Stabilisation of medically refractory ventricular arrhythmias by intra-aortic balloon counterpulsation. Heart,1999,82:96-100.
4Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coil Cardiol,2001,38 : 1456-1462.
5Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J,2003,24:1763-1770.
6Stone GW, Ohman EM, MillerM F, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol, 2003, 41:1940-1945.
7Ohman EM, George BS, White C J, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized triM. The Randomized IABP Study Group. Circulation, 1994,90:792-799.
8Mishra S, Chu WW, Torgnson R, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol,2006 ,98 :608-612.
9Stone GW, Marsalese D, Brodil BR, et al. A prospective, randomized evaluation of prophylactic intra aortic balloon counter pulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-Ⅱ) Trial Investigators. J Am Coll Cardiol, 1997,29 : 1459-1467.
10Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients : observations from a randomized trial to explore its mode of action. J Invasive Cardiol, 2007,19 : 339- 346.